ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

EU GMP Lab Design & Consulting Services For Pharmaceutical Compliance Expanded

Hempire Labs S.L. has expanded its laboratory design services to support pharmaceutical producers in meeting rigorous manufacturing and regulatory standards.

-- The Spain-based consultancy's expanded laboratory design offerings are suited to meet the growing demand for Good Manufacturing Practice (GMP)-compliant facilities in the pharmaceutical cannabis sector.

More details can be found at https://hempirelabs.com

Recent market data shows the global cannabis testing services sector was valued at USD 1.8 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 17.21% through 2030. This trend is expected to drive demand for certified laboratories capable of supporting medical-grade cannabis production, Hempire Labs explains.

The consultancy's design capabilities now encompass cleanroom engineering, extraction lab layouts, and processing facility planning—key components in ensuring regulatory compliance and product integrity. With its services, Hempire Labs's goal is to help cannabis producers address the increasing pressure to meet rigorous pharmaceutical standards.

The team comprises experts in cannabis extraction, purification processes, and regulatory frameworks. Their design process integrates GMP, Good Distribution Practice (GDP), and Good Agricultural and Collection Practice (GACP) standards—requirements critical for securing market access and ensuring product safety.

About Hempire Labs S.L.

Hempire Labs provides consulting services for medical cannabis companies worldwide. The company specializes in GMP compliance, laboratory design, and project management. Based in Sotogrande, Cadiz, Spain, Hempire Labs works with both startups and established firms in the cannabis industry.

Co-founder Mardi Joubanian brings a background in pharmaceutical lab implementation, with a focus on high-purity extraction and purification systems. Fellow co-founder Paulina Molyneux-Webb contributes project management expertise and a professional history in herbal formulations and regulatory compliance.

"Whether you are looking for assistance in cannabis cultivation, product development, business strategy and growth, or compliance and legal support, our team of highly-experienced consultants will work with you every step of the way to bring your vision to life," the consultancy says.

For more information about consulting services, interested parties can visit https://hempirelabs.com

Contact Info:
Name: Paulina Molyneux-Webb
Email: Send Email
Organization: Hempire Labs S.L.
Address: C.C., Mar y Sol Local 3.9, Sotogrande, Andalucía 11310, Spain
Website: https://hempirelabs.com

Source: NewsNetwork

Release ID: 89164291

In the event of encountering any errors, concerns, or inconsistencies within the content shared in this press release, we kindly request that you immediately contact us at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our dedicated team will be readily accessible to address your feedback within 8 hours and take appropriate measures to rectify any identified issues or facilitate press release takedowns. Ensuring accuracy and reliability are central to our commitment.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.